Angela Poff and colleagues investigated whether two metabolic interventions together could be more effective against metastatic cancer than either intervention alone.

In a 2013 VM-M3 mouse study, ketogenic diet (KD) alone increased mean survival by 56.7% compared with controls. Combining KD with hyperbaric oxygen therapy (HBOT) increased mean survival by 77.9%. HBOT alone did not significantly slow tumor progression.
That difference raises a straightforward question: can interventions acting on distinct aspects of tumor metabolism strengthen one another? KD changes systemic fuel availability. HBOT changes oxygen exposure. The combination produced a stronger result in this mouse model than either approach alone.
The image also illustrates a later experimental interest in ketone esters (KE), which should not be confused with the KD-versus-HBOT survival percentages. These findings are from experimental mouse models and do not establish a cancer treatment for patients.
Source: Poff et al. (2013), PLOS ONE, doi:10.1371/journal.pone.0065522.
